Euclidean Technologies Management’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-846
Closed -$223K 69
2022
Q2
$223K Hold
846
0.23% 61
2022
Q1
$203K Buy
+846
New +$198K 0.19% 79
2021
Q3
Sell
-846
Closed -$201K 86
2021
Q2
$201K Buy
+846
New +$211K 0.16% 89
2019
Q1
Sell
-6,142
Closed -$1.17M 68
2018
Q4
$1.17M Buy
+6,142
New +$1.28M 1.21% 44

Other funds holding CI

Euclidean Technologies Management's CI Position: Q3 2022 in Review

Euclidean Technologies Management sold out of Cigna (CI) in Q3 2022, closing a stake of 846 shares — an estimated $223K sold.

Euclidean Technologies Management first reported a position in CI in Q4 2018 and held it in 4 quarters. The position peaked at $1.17M in Q4 2018. 1,482 funds tracked by Wall St. Rank hold CI as of Q3 2022.

  • Euclidean Technologies Management reported no remaining Cigna position as of Q3 2022 after selling out during the quarter.
  • Euclidean Technologies Management sold 846 Cigna shares in Q3 2022, an estimated $223K.
  • Euclidean Technologies Management first reported a position in Cigna in Q4 2018 and held it in 4 quarters.
  • Euclidean Technologies Management's Cigna position peaked at $1.17M in Q4 2018.
  • 1,482 funds tracked by Wall St. Rank held Cigna as of Q3 2022.

Based on Euclidean Technologies Management's 13F filing for Q3 2022, filed 28 Oct 2022.